Stanford University
Showing 4,751-4,800 of 36,221 Results
-
Spencer Chang
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Spencer Chang is a board-certified Internal Medicine physician who practices at the Stanford Internal Medicine Clinic in Palo Alto. Dr. Chang earned his MD at Duke University School of Medicine where he was part of the Primary Care Leadership Track. He completed his Internal Medicine Residency training at UCLA in the Primary Care Program. Dr. Chang has interests in medical education, improving access to primary care, community health, and Asian Pacific Islander health disparities. He believes in a holistic approach to patient care, addressing the physical, mental, and emotional well-being of his patients and partnering with them to achieve their health goals.
-
Stephanie Tzu-Ying Chang
Assistant Professor of Radiology
BioDr. Stephanie Chang is an Assistant Professor in Radiology at Stanford University School of Medicine and Interim Director of Diagnostic Radiology in the Department of Radiology at VA Palo Alto.
Dr. Chang’s research program aims to utilize state-of-the-art diagnostic technology to non-invasively detect abdominal diseases that predispose or lead to cancer since the most beneficial and cost-effective cancer imaging occurs in the screening/early detection phase.
Currently, metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are leading worldwide causes of end-stage liver disease and liver cancer (hepatocellular carcinoma, HCC). To determine the optimal multimodality screening and diagnostic pathway, Dr. Chang leads prospective research studies at VA Palo Alto comparing blood-based and imaging-based diagnostic tests – the Fibrosis-4 (FIB-4) Index, the Enhanced Liver Fibrosis (ELF) test, vibration controlled transient elastography (VCTE), ultrasound point shear wave elastography (US pSWE), and magnetic resonance imaging (MRI) elastography – among high-risk veterans with obesity and/or type 2 diabetes to compare relative performance and costs/benefits.
To improve detection of hepatocellular carcinoma (HCC) among patients with end-stage liver disease (cirrhosis), Dr. Chang also serves as a member of the VA National Radiology Working Group and radiology local site investigator at VA Palo Alto for a multicenter VA research study CSP #2023 PREventing liver cancer Mortality through Imaging with Ultrasound vs. MRI (PREMIUM STUDY) comparing US and MRI to determine optimal screening strategies for hepatocellular carcinoma.
While MRI has the overall highest sensitivity and specificity for many diseases and contains additional biological/prognostic information not obtainable via other imaging methods, the utility of MRI as a powerful non-invasive screening tool has been hampered by its limitations in access, time, and cost. Dr. Chang is interested in significantly shortening MRI exam times to accelerate MRI throughput, decrease patient discomfort, and reduce costs. To accomplish this goal, Dr. Chang is interested in improving pulse sequences to shorten MRI acquisition times while maintaining or increasing diagnostic quality. In addition, Dr. Chang is interested in novel MRI techniques to improve disease detection and staging. -
Stephen Chang, MD, PhD
Instructor, Biochemistry
Instructor, Medicine - Cardiovascular MedicineBioPrior to a career in medicine, Dr. Chang was an English major and subsequent novelist at night. During the days, he taught literature part-time at Rutgers University, and for extra money, worked in a laboratory in NYC washing test tubes. Inspired by his laboratory mentor, he began volunteering at the hospital next door, and developed a love for interacting with patients. Through this experience, he saw how caring for others could form deep bonds between people - even strangers - and connect us in a way that brings grandeur to ordinary life.
In addition to seeing patients, Dr. Chang is a physician-scientist devoted to advancing the field of cardiovascular medicine. His research has been focused on identifying a new genetic organism that better models human heart disease than the mouse. For this purpose, he has been studying the mouse lemur, the smallest non-human primate, performing cardiovascular phenotyping (vital signs, ECG, echocardiogram) on lemurs both in-bred (in France) and in the wild (in Madagascar) to try to identify mutant cardiac traits that may be heritable - and in the process, characterize the first high-throughput primate model of human cardiac disease. -
Steven D. Chang, MD
Robert C. and Jeannette Powell Neurosciences Professor and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology and Neurological Sciences
Current Research and Scholarly InterestsClinical research includes studies in the treatment of cerebrovascular disorders, such as aneurysms and AVMs, as well as the use of radiosurgery to treat tumors and vascular malformations of the brain and spine.
Dr. Chang is C0-Director of the Cyberknife Radiosurgery Program.
Dr. Chang is also the head of the The Stanford Neuromolecular Innovation Program with the goal of developing new technologies to improve the diagnosis and treatment of patients affected by neurological conditions. -
Tara I. Chang
Stanford University Professor of Nephrology
Current Research and Scholarly InterestsMy research focuses on issues such as blood pressure control, coronary revascularization, and the comparative effectiveness of cardioprotective medications in patients with chronic kidney disease, with the long-term goal of improving cardiovascular outcomes in these high-risk patients.
-
Timothy C. Chang
Clinical Assistant Professor, Urology
BioDr. Timothy Chang is a Clinical Assistant Professor of Urology at Stanford University. He graduated with High Honors from Princeton University and received a Master of Science from Massachusetts Institute of Technology. He then obtained his medical degree and urology residency training from Stanford University School of Medicine. Dr. Chang has experience in a broad range of adult general urologic care, with a particular focus on kidney stone treatment for which he completed specialized fellowship training at Stanford. He received multiple research awards and authored or co-authored numerous academic publications. With his experience in both the engineering and medical fields, he has particular interest in developing technological medical advancements.
-
Yan Chang
Ph.D. Student in Japanese, admitted Autumn 2021
BioYan Chang is a Ph.D. student in modern and contemporary East Asian literatures, cultures, and media. His research interests currently center on trans-linguality, trans-culture, and trans-nationality in post-Cold War Japanophone literature. His academic concerns also include visuality and modernity of modern Japanese literature in the Taisho period as well as Shanghai urbanization and the concomitant media representations in the 1990s. Before joining Stanford, Yan received a joint B.A. in Economics and Japanese from Shanghai International Studies University, an M.A. in Japanese Culture Studies from Nagoya University, and an M.A. in Asian and Middle Eastern Studies from the University of Minnesota at Twin Cities.
-
Yihe M. Chang
Undergraduate, Economics
Research Assistant, SIEPR OperationsBioAn aspiring economist focusing on international development; a passionate organist and choral conductor.
-
Ying Chih Chang
Adjunct Professor, Chemical Engineering
BioDr. Ying Chang is the Chair of the Taiwan Science and Technology Hub and an Adjunct Professor in the Department of Chemical Engineering at Stanford University. She is also the Founder and CEO of Acrocyte Therapeutics, Inc.
Her former faculty appointments include Research Fellow (-Associate Fellow) at the Genomics Research Center, Academia Sinica, Taiwan, and Assistant Professor in the Departments of Chemical Engineering and Materials Science, and Biomedical Engineering at the University of California, Irvine. The research highlights include integrating nanomaterials, microfluidics, and bioreactors to control cell fates for tissue engineering, as well as developing circulating tumor cell 3D culture for cancer diagnostics and precision medicine. She holds multiple patents in DNA microarray constructs (assigned to Affymetrix), circulating tumor cell isolation and cancer screening (assigned to Cellmax Life Inc.), and single cell derived scaffold free 3D culture platform RCE and circulating tumor cell liquid biopsy drug test (assigned to Acrocyte Therapeutics Inc. www.acrocyte.com).
Dr. Chang’s work was recognized by the Young Investigator Award from the Whitaker Foundation, FDA breakthrough device designation for pre-cancer and cancer detection (2021), Future Tech Award (2021), 18th National Innovation Award, Taiwan (2021), and Finalist at Startup Stadium at BIO 2024, among other. She is also on the board of trustees of Kaohsiaung Medical University, and Chang Chau-Ting Memorial Foundation, a non-profit organization for science education and awareness in Taiwan. She received her BS from National Taiwan University, and PhD from Stanford University, both in Chemical Engineering. -
Lisa Chao, MD, FACOG
Clinical Associate Professor, Obstetrics & Gynecology
BioDr. Lisa Chao is a fellowship-trained, minimally invasive gynecologic surgeon who specializes in complex pelvic surgery for benign gynecologic conditions including endometriosis, pelvic pain, uterine fibroids, abnormal uterine bleeding, adnexal cysts, and other conditions that may require minimally invasive surgery. She is devoted to improving women’s health through evidence-based practice and by providing compassionate, holistic, and patient-centered approach to care. Committed to helping those with endometriosis and pelvic pain, she takes on a multimodal and multidisciplinary approach. Her clinical interests include complex gynecologic surgery, advanced laparoscopic techniques, large fibroids, advanced endometriosis, and pelvic pain. Her academic interests include surgical education and simulation training.
Dr. Chao earned her medical degree at the University of Illinois College of Medicine. She completed a residency in obstetrics and gynecology at Stanford University and received advanced training in minimally invasive gynecologic surgery through a fellowship at the University of Pittsburgh Medical Center’s Magee-Womens Hospital. Prior to returning to Stanford University, she was a member of the faculty at the University of Texas Southwestern Medical Center in Dallas, TX and served as Associate Director of the Minimally Invasive Gynecologic Surgery Fellowship Program where she trained both fellows and residents.
Dr. Chao has authored many peer-reviewed research articles and delivered numerous presentations at international meetings. She is a peer reviewer for the American Journal of Obstetrics and Gynecology and has been a ‘Top Reviewer’ since 2020 for the journal, Obstetrics and Gynecology. She is also an active member of the American Association of Gynecologic Laparoscopists (AAGL), the American College of Obstetricians and Gynecologists (ACOG), and the Society of Gynecologic Surgeons (SGS). She holds leadership positions and serves as an expert on several national committees for these organizations. -
Stephanie D. Chao, MD FACS FAAP
Associate Professor of Surgery (Pediatric Surgery) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsDr. Chao is passionate about disease prevention as she believes it is the ultimate way to impact the health of a population. Surgeons often see the devastating, end-results of the failure of prevention. With this perspective, Dr. Chao believes that it is crucial for surgeons to be active in prevention research. Dr. Chao currently serves as Trauma Medical Director of Lucile Packard Children’s Hospital and focuses much of her research on injury prevention.
-
Steven Z. Chao
Clinical Professor (Affiliated), Adult Neurology
Staff, Neurology ResearchBioDr. Steven Chao graduated from UCLA in biochemistry with highest honors, Summa Cum Laude. He then finished his combined MD/PhD training program from Chicago Medical School/Rosalind Franklin University with AOA Honors. Following his neurology residency at Stanford, he continued with a behavior neurology fellowship training at UCSF Memory and Aging Center, where he started research in dementia.
Currently, He serves as a staff neurologist at the Palo Alto VA and with an appointment at the Stanford Department of Neurology as a clinical professor (affiliated). His current research interest is in early imaging diagnosis of dementia and early treatment/prevention of Alzheimer’s disease, cognitive treatment in traumatic brain injury, and alternative treatments for headache.
Community and academic education about dementia and cognitive health has always been his passion, and he continues to publish research articles and book chapters to support clinical education. -
Tiffany E. Chao, MD, MPH, FACS, FCS (ECSA)
Adjunct Professor
BioDr. Tiffany E. Chao is a board-certified general surgeon at Santa Clara Valley Medical Center (SCVMC), a Clinical Associate Professor of Surgery (Affiliated) in the Stanford Department of Surgery (Division of General Surgery), and an Adjunct Professor in the university's Program in Human Biology. At SCVMC, Dr. Chao is the Site Director for the Stanford medical student surgical clerkship and the Associate Site Director for the Stanford General Surgery Residency Program. Her interests in surgery include minimally invasive foregut, hernia, and colorectal surgery, in addition to acute care & trauma surgery.
At Stanford, she is the Primary Instructor of the undergraduate course HUMBIO 29: Introduction to Global Health and the medical school seminar SURG 236: Seminar in Global Surgery and Anesthesia, both Winter Quarter classes. Her other roles at Stanford include Faculty Fellow with Center for Innovation in Global Health and the Clinical Competency Committee of the General Surgery Residency. Dr. Chao's research interests are in global surgery, including cost-effectiveness analysis, surgical device innovation, and expansion of surgical delivery for low-income populations through surgical workforce and infrastructure development.
Dr. Chao holds dual Bachelor's degrees in Symbolic Systems and Psychology from Stanford University, as well as MD and MPH degrees from Mount Sinai School of Medicine, where she graduated with Alpha Omega Alpha honors. She completed General Surgery residency at the Massachusetts General Hospital in Boston, the Paul Farmer Global Surgery Research Fellowship at Harvard Medical School's Program in Global Surgery and Social Change, and the CTSA/Lucile Packard Innovation Fellowship at Stanford Biodesign. Through the Biodesign program, she co-founded Zenflow, Inc., a venture-backed medical device company working in minimally-invasive therapy for prostate disease, and is a Founding Partner of 4i Ventures.
In addition to being a Fellow of the American College of Surgeons since 2018, Dr. Chao was also elected to be an Overseas Fellow of The College of Surgeons of East, Central and Southern Africa (COSECSA) in 2022. She has also been appointed as an Extraordinary Senior Lecturer at the Centre for Global Surgery at Stellenbosch University in Cape Town, South Africa and serves on the Editorial Board of the World Journal of Surgery. -
Emilee Chapman
Associate Professor of Political Science
BioEmilee is an Associate Professor of Political Science at Stanford. Her primary research and teaching interests are in democratic theory and political ethics.
